Human genome editing – the issues explored
Hayley Clissold from the Sanger Institute’s policy team team explores the issues surrounding gene editing and human embryos
Read moreHayley Clissold from the Sanger Institute’s policy team team explores the issues surrounding gene editing and human embryos
Read moreEvidence is a vital part of policy-making – but it’s by no means the only part. We look at how scientists can get involved and make a difference.
Read moreOur Policy Lead, Sarion Bowers, explores the extraordinary claims that the world’s first genome edited babies have been born.
Read moreAnna Middleton, Head of the Society and Ethics research group at Wellcome Genome Campus Connecting Science, reports on Prof He Jiankiu’s unverified announcement of gene editing the first human embryos that have been born
Read moreThe idea that we should benefit from scientific advancement is something we may never have thought of as human right, yet the Universal Declaration of Human Rights firmly makes the case that it is everyone’s right, regardless of education, wealth or background, explains Sarion Bowers
Read moreFrom one human genome to hundreds of thousands, to every single cell in the body, to the genome of every species on the planet – DNA sequencing is accelerating. On our 25th anniversary we look at the evolution, application and potential of this powerful science.
Read more03.08.17 This week the American Society of Human Genetics issued a policy on the application of germline editing – the ability to alter the genetic makeup of early stage embryos. Anna Middleton, one of the contributors to the statement, explains the policy’s position
Read more04.07.17 The UK Chief Medical Officer’s Report has highlighted the vital role genetics and genomics will play in UK NHS healthcare and medicine. Professor Sharon Peacock helped write the report’s chapter on Infectious disease.
Read more